SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MRNA-4157 IN COMBINATION WITH PEMBROLIZUMAB IN SUBJECTS WITH UNRESECTABLE SOLID TUMORS (KEYNOTE-603): AN UPDATE-MedSci.cn

SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MRNA-4157 IN COMBINATION WITH PEMBROLIZUMAB IN SUBJECTS WITH UNRESECTABLE SOLID TUMORS (KEYNOTE-603): AN UPDATE

Bauman, J; Burris, H; Clarke, J; Patel, M; Cho, D; Gutierrez, M; Julian, R; Scott, A; Cohen, P; Frederick, J; Robert-Tissot, C; Zhou, HH; Mody, K; Keating, K; Meehan, R; Gainor, J

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020; 8 (): A477

科室
- - 订阅+
  - 更多科室
工具
服务